Previous close | 12.37 |
Open | 14.78 |
Bid | 14.81 x 150000 |
Ask | 15.11 x 150000 |
Day's range | 14.78 - 14.78 |
52-week range | 6.24 - 32.71 |
Volume | |
Avg. volume | 546 |
Market cap | 2.744B |
Beta (5Y monthly) | 2.32 |
PE ratio (TTM) | 184.75 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Despite a net loss, TG Therapeutics Inc reports significant revenue increases and strategic advancements in Q1 2024, setting a positive trajectory for the year.
Q1 2024 TG Therapeutics Inc Earnings Call
Comprehensive Analysis of TG Therapeutics' First Quarter Financial Performance